Investors & Media


February 28, 2022

Sage Therapeutics to Present at the Cowen 42nd Annual Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 28, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced today that the Company will participate in a fireside chat at the Cowen 42nd Annual Healthcare Conference on Monday, March 7, 2022 at 10:30am ET.

A live webcast of the fireside chat can be accessed on the Investor page of Sage’s website at A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit.

Investor Contact
Helen Rubinstein

Media Contact
Maureen L. Suda

Source: Sage Therapeutics, Inc.